Keyphrases
Cervical Cancer
69%
Brachytherapy Treatment Planning
26%
Percolation Transition
23%
Knowledge Base
23%
Topological Heterostructure
23%
Normal Tissue Complication Probability Models
23%
Interpretable Deep Learning
23%
Knowledge-based Planning
23%
Organ Dose
23%
Relative Seriality
23%
Bone Marrow Sparing
23%
Wolfram Language
23%
Prediction Tool
23%
Atlas-based Auto-segmentation
23%
Rectum
23%
Topological Insulator
23%
Weak Localization
23%
Dose Prediction
23%
Gut Microbial Colonization
23%
Imaging Biomarkers
23%
Bladder
23%
Liquid Biopsy
23%
Training Set
22%
Histogram Estimation
18%
Dose-volume Histogram
18%
Cervical Cancer Prevention
14%
Validation Set
13%
Degrading Strains
11%
Nucleic Acid Database
11%
Shear Sliding
11%
Positron Emission Tomography
11%
Van Der Waals Density Functional Theory
11%
Energy Modulation
11%
Tearing Mode
11%
Magnetic Resonance Imaging
11%
Computed Tomography
11%
Early Colonization
11%
Punctuated Change
11%
Cervical Cancer Radiotherapy
9%
Boundary Distance
9%
High-risk Clinical Target Volume
9%
At-risk
9%
Brachytherapy
9%
Categorical Variables
9%
Brachytherapy Planning
9%
Quality Control
7%
Normal Tissue Complication Probability
7%
Non-topological
6%
Knowledge Application
6%
Multicenter Clinical Trial
6%
Medicine and Dentistry
Cervical Cancer
100%
Positron Emission Tomography-Computed Tomography
53%
Biological Marker
36%
Bladder
30%
Radiation Therapy
28%
Treatment Planning
26%
Radiomics
26%
Brachytherapy
26%
Neoplasm
23%
Targeted Radionuclide Therapy
23%
Dose-Volume Histogram
23%
Sigmoid
23%
Pelvis
23%
Clinical Trial
23%
DNA Damage
23%
Liquid Biopsy
23%
Cancer Radiotherapy
11%
Dosimetry
11%
In Vitro
11%
Fluorodeoxyglucose F 18
9%
Chemoradiotherapy
9%
Proportional Hazards Model
9%
Intracavitary Brachytherapy
8%
Linear Regression Analysis
7%
Magnetic Resonance Imaging
7%
Positron Emission Tomography
7%
Treatment Response
7%
Femoral Head
7%
Standardized Uptake Value
7%
Intensity Modulated Radiation Therapy
7%
Computer Assisted Tomography
7%
Disease
6%
Bladder Capacity
5%
Radiopharmaceutical Agent
5%
Cell Death
5%
Cell Survival
5%
Chromosome Aberration
5%
Dose Response
5%
Lutetium 177
5%
Student T Test
5%
Neuroendocrine Tumor
5%
Tumor Cell
5%
Health Care Cost
5%
Double Stranded DNA
5%
In Silico
5%
Analysis of Variance
5%